Intellia Therapeutics Aktie
8,32
EUR
+0,52
EUR
+6,69
%
9,60
USD
±0,00
USD
±0,00
%
Werbung
Intellia Therapeutics Aktie Analyse
02.11.18 | Intellia Therapeutics Neutral | Wedbush Morgan Securities Inc. | |
15.05.18 | Intellia Therapeutics Buy | Chardan Capital Markets | |
28.03.17 | Intellia Therapeutics Buy | Chardan Capital Markets | |
31.05.16 | Intellia Therapeutics Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung